When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
CLRB - Cellectar Bio down 23% premarket on mid-stage CLR 131 data
Cellectar Biosciences Inc.
Thinly traded nano cap Cellectar Biosciences (NASDAQ:CLRB) slumps 23% premarket on increased volume in reaction to results from a Phase 2 clinical trial, CLOVER-1, evaluating lead candidater CLR 131 in patients with relapsed/refractory B-cell lymphomas.
More news on: Cellectar Biosciences, Inc., Healthcare stocks news, Stocks on the move,